Stifel Financial Corp decreased its stake in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 45.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 57,166 shares of the semiconductor company's stock after selling 47,420 shares during the period. Stifel Financial Corp owned 0.18% of Silicon Laboratories worth $7,101,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in SLAB. Capital Research Global Investors increased its stake in shares of Silicon Laboratories by 23.3% in the fourth quarter. Capital Research Global Investors now owns 2,131,920 shares of the semiconductor company's stock valued at $264,827,000 after buying an additional 403,010 shares during the period. Norges Bank acquired a new stake in Silicon Laboratories during the fourth quarter worth approximately $34,622,000. Invesco Ltd. grew its stake in Silicon Laboratories by 46.9% during the fourth quarter. Invesco Ltd. now owns 595,382 shares of the semiconductor company's stock worth $73,958,000 after purchasing an additional 190,085 shares during the period. Raymond James Financial Inc. acquired a new stake in Silicon Laboratories during the fourth quarter worth approximately $14,252,000. Finally, Alliancebernstein L.P. grew its stake in Silicon Laboratories by 58.2% during the fourth quarter. Alliancebernstein L.P. now owns 240,321 shares of the semiconductor company's stock worth $29,853,000 after purchasing an additional 88,438 shares during the period.
Insider Activity
In related news, Director William G. Bock sold 1,000 shares of Silicon Laboratories stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the sale, the director now directly owns 31,115 shares in the company, valued at approximately $4,649,514.45. This trade represents a 3.11 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Navdeep S. Sooch sold 2,360 shares of Silicon Laboratories stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total value of $351,640.00. Following the sale, the director now owns 400,567 shares in the company, valued at $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.
Silicon Laboratories Stock Down 0.1 %
SLAB stock opened at $102.62 on Tuesday. Silicon Laboratories Inc. has a twelve month low of $82.82 and a twelve month high of $160.00. The stock's 50 day moving average is $115.59 and its 200-day moving average is $120.99. The firm has a market capitalization of $3.33 billion, a PE ratio of -17.28 and a beta of 1.33.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The company had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. During the same quarter last year, the company earned ($1.19) earnings per share. The company's revenue for the quarter was up 91.4% on a year-over-year basis. On average, equities research analysts anticipate that Silicon Laboratories Inc. will post -0.97 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
SLAB has been the subject of several recent analyst reports. StockNews.com cut Silicon Laboratories from a "hold" rating to a "sell" rating in a research note on Thursday, March 27th. Needham & Company LLC reaffirmed a "buy" rating and set a $150.00 target price on shares of Silicon Laboratories in a research note on Wednesday, March 12th. KeyCorp raised their target price on Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 22nd. Barclays decreased their target price on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 22nd. Finally, Stifel Nicolaus reduced their price objective on Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research note on Thursday, April 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Silicon Laboratories presently has an average rating of "Hold" and an average price target of $129.00.
Get Our Latest Analysis on SLAB
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report